FDA Import Refusal AEK-2085709-9/20003/1 — BOEHRINGER INGELHEIM
The FDA refused shipment AEK-2085709-9/20003/1 from BOEHRINGER INGELHEIM (Mexico) on Sep 24, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 24, 2026
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,75